Health Trials

HER2-positive Recurrent or Metastatic Malignant Solid Tumor

1

Review clinical trials related to HER2-positive Recurrent or Metastatic Malignant Solid Tumor. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor

This is a phase I study evaluating the safety and pharmacokinetics of MBS301 after intravenous administration in patients with HER-2 positive recurrent or metastatic malignant solid tumors

Participants needed: 34
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Beijing Mabworks Biotech Co., Ltd.Updated: Nov 20, 2024Locations: 1
Eligibility criteria

Patients with HER2-positive recurrent or metastatic malignant solid tumor diagno... [+4]

Absolute neutrophils count (ANC) is less than1.5×109/L and/or blood platelets le... [+9]

Read more